Therapeutic Approaches to Target Inflammation in Type 2 Diabetes

被引：102

作者：

Goldfine, Allison B. ^{[1
,2
]}

Fonseca, Vivian ^{[3
]}

Shoelson, Steven E. ^{[1
,2
]}

机构：

[1] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA

[3] Tulane Univ, Dept Med, Endocrinol Sect, New Orleans, LA 70118 USA

来源：

CLINICAL CHEMISTRY | 2011年 / 57卷 / 02期

关键词：

C-REACTIVE PROTEIN; NF-KAPPA-B; INDUCED INSULIN-RESISTANCE; SODIUM-SALICYLATE; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; IKK-BETA; RANDOMIZED-TRIAL; STATIN THERAPY; OBESE SUBJECTS;

D O I：

10.1373/clinchem.2010.148833

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

BACKGROUND: Chronic inflammation may participate in the pathogenesis of insulin resistance, type 2 diabetes, and cardiovascular disease and may be a common denominator that links obesity to these disease states. CONTENT: Epidemiologic studies have linked inflammatory biomarkers to incident diabetes and cardiovascular disease risk. Cellular and animal studies have provided support to the idea that inflammation mediates these disease processes, providing impetus to pharmacologically target these pathways for disease treatment and prevention. We review clinical strategies to target inflammation, with a focus on the antiinflammatory and antihyperglycemic effects of salicylates. SUMMARY: The evolving concept of diet-induced obesity driving insulin resistance, type 2 diabetes, and cardiovascular disease through immunologic processes provides new opportunities for the use of antiinflammatory strategies to correct the metabolic consequences of excess adiposity. (C) 2010 American Association for Clinical Chemistry

引用

页码：162 / 167

页数：6

共 46 条

[1] The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away [J].

Alverdy, John C. ;

Chang, Eugene B. .

JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 83 (03) :461-466

[2] IKK-β links inflammation to obesity-induced insulin resistance [J].

Arkan, MC ;

Hevener, AL ;

Greten, FR ;

Maeda, S ;

Li, ZW ;

Long, JM ;

Wynshaw-Boris, A ;

Poli, G ;

Olefsky, J ;

Karin, M .

NATURE MEDICINE, 2005, 11 (02) :191-198

[3] Effects of statins on nonlipid serum markers associated with cardiovascular disease - A systematic review [J].

Balk, EM ;

Lau, J ;

Goudas, LC ;

Jordan, HS ;

Kupelnick, B ;

Kim, LU ;

Karas, RH .

ANNALS OF INTERNAL MEDICINE, 2003, 139 (08) :670-682

[4] Effects of etanercept in patients with the metabolic syndrome [J].

Bernstein, LE ;

Berry, J ;

Kim, S ;

Canavan, B ;

Grinspoon, SK .

ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (08) :902-908

[5] IKKβ/NF-κB activation causes severe muscle wasting in mice [J].

Cai, DS ;

Frantz, JD ;

Tawa, NE ;

Melendez, PA ;

Oh, BC ;

Lidov, HGW ;

Hasselgren, PO ;

Frontera, WR ;

Lee, J ;

Glass, DJ ;

Shoelson, SE .

CELL, 2004, 119 (02) :285-298

[6] Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB [J].

Cai, DS ;

Yuan, MS ;

Frantz, DF ;

Melendez, PA ;

Hansen, L ;

Lee, J ;

Shoelson, SE .

NATURE MEDICINE, 2005, 11 (02) :183-190

[7] RESTORATION OF ACUTE INSULIN-RESPONSE BY SODIUM SALICYLATE - GLUCOSE DOSE-RELATED PHENOMENON [J].

CHEN, M ;

ROBERTSON, RP .

DIABETES, 1978, 27 (07) :750-756

[8] Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects:: Evidence for an anti-inflammatory effect? [J].

Dandona, P ;

Aljada, A ;

Mohanty, P ;

Ghanim, H ;

Hamouda, W ;

Assian, E ;

Ahmad, S .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3257-3265

[9] The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus [J].

Donath, Marc Y. ;

Mandrup-Poulsen, Thomas .

NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (05) :240-241

[10]

Ebstein W., 1876, BERLINER KLIN WOCHEN, V13, P337

← 1 2 3 4 5 →